Bimiralisib
- Generic Name
- Bimiralisib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C17H20F3N7O2
- CAS Number
- 1225037-39-7
- Unique Ingredient Identifier
- 6Z3QHB00LB
- Background
Bimiralisib is under investigation in clinical trial NCT02723877 (PQR309 and Eribulin in Metastatic HER2 Negative and Triple-negative Breast Cancer (PIQHASSO)).
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath